An approach for automatic classification of grouper vocalizations with passive acoustic monitoring
Ibrahim, Ali K, Chérubin, Laurent M, Zhuang, Hanqi, Schärer Umpierre, Michelle T, Dalgleish, Fraser, Erdol, Nurgun, Ouyang, B, Dalgleish, A
Published in The Journal of the Acoustical Society of America (01.02.2018)
Published in The Journal of the Acoustical Society of America (01.02.2018)
Get more information
Journal Article
Gemcitabine alters the proteasome composition and immunopeptidome of tumour cells
Gravett, A. M., Stevanović, S., Dalgleish, A. G., Copier, J.
Published in Oncoimmunology (03.06.2018)
Published in Oncoimmunology (03.06.2018)
Get full text
Journal Article
Phase I Study of an Immunomodulatory Thalidomide Analog, CC-4047, in Relapsed or Refractory Multiple Myeloma
SCHEY, S. A, FIELDS, P, BARTLETT, J. B, CLARKE, I. A, ASHAN, G, KNIGHT, R. D, STREETLY, M, DALGLEISH, A. G
Published in Journal of clinical oncology (15.08.2004)
Published in Journal of clinical oncology (15.08.2004)
Get full text
Journal Article
Anti-tumour activity of afatinib, an irreversible ErbB family blocker, in human pancreatic tumour cells
IOANNOU, N, DALGLEISH, A. G, SEDDON, A. M, MACKINTOSH, D, GUERTLER, U, SOLCA, F, MODJTAHEDI, H
Published in British journal of cancer (08.11.2011)
Published in British journal of cancer (08.11.2011)
Get full text
Journal Article
Bacillus Calmette-Guerin (BCG) induces superior anti-tumour responses by Vδ2+ T cells compared with the aminobisphosphonate drug zoledronic acid
Fenn, J, Ridgley, L A, White, A, Sarfas, C, Dennis, M, Dalgleish, A, Reljic, R, Sharpe, S, Bodman-Smith, M
Published in Clinical and experimental immunology (23.06.2022)
Published in Clinical and experimental immunology (23.06.2022)
Get full text
Journal Article
Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects
DREDGE, K, MARRIOTT, J. B, MACDONALD, C. D, MAN, H-W, CHEN, R, MULLER, G. W, STIRLING, D, DALGLEISH, A. G
Published in British journal of cancer (04.11.2002)
Published in British journal of cancer (04.11.2002)
Get full text
Journal Article
Effect of Gemcitabine based chemotherapy on the immunogenicity of pancreatic tumour cells and T-cells
Smith, P. L., Yogaratnam, Y., Samad, M., Kasow, S., Dalgleish, A. G.
Published in Clinical & translational oncology (01.01.2021)
Published in Clinical & translational oncology (01.01.2021)
Get full text
Journal Article
Mechanisms of action of tasquinimod on the tumour microenvironment
Raymond, E., Dalgleish, A., Damber, J.-E., Smith, M., Pili, R.
Published in Cancer chemotherapy and pharmacology (01.01.2014)
Published in Cancer chemotherapy and pharmacology (01.01.2014)
Get full text
Journal Article
An intra-patient placebo-controlled phase I trial to evaluate the safety and tolerability of intradermal IMM-101 in melanoma
Stebbing, J., Dalgleish, A., Gifford-Moore, A., Martin, A., Gleeson, C., Wilson, G., Brunet, L.R., Grange, J., Mudan, S.
Published in Annals of oncology (01.05.2012)
Published in Annals of oncology (01.05.2012)
Get full text
Journal Article
T-regulatory cell modulation: the future of cancer immunotherapy?
NIZAR, S, COPIER, J, MEYER, B, BODMAN-SMITH, M, GALUSTIAN, C, KUMAR, D, DALGLEISH, A
Published in British journal of cancer (02.06.2009)
Published in British journal of cancer (02.06.2009)
Get full text
Journal Article
Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations
Pollard, P.J., Brière, J.J., Alam, N.A., Barwell, J., Barclay, E., Wortham, N.C., Hunt, T., Mitchell, M., Olpin, S., Moat, S.J., Hargreaves, I.P., Heales, S.J., Chung, Y.L., Griffiths, J.R., Dalgleish, A., McGrath, J.A., Gleeson, M.J., Hodgson, S.V., Poulsom, R., Rustin, P., Tomlinson, I.P.M.
Published in Human molecular genetics (01.08.2005)
Published in Human molecular genetics (01.08.2005)
Get full text
Journal Article
Review article: immune suppression and colorectal cancer
EVANS, C., DALGLEISH, A. G., KUMAR, D.
Published in Alimentary pharmacology & therapeutics (15.10.2006)
Published in Alimentary pharmacology & therapeutics (15.10.2006)
Get full text
Journal Article
Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers
BARTLETT, J. B, MICHAE, A, ZELDIS, J, DALGLEISH, A. G, CLARKE, I. A, DREDGE, K, NICHOLSON, S, KRISTELEIT, H, POLYCHRONIS, A, PANDHA, H, MULLER, G. W, STIRLING, Dl
Published in British journal of cancer (08.03.2004)
Published in British journal of cancer (08.03.2004)
Get full text
Journal Article
Improving the efficacy of cancer immunotherapy
Copier, J, Dalgleish, A.G, Britten, C.M, Finke, L.H, Gaudernack, G, Gnjatic, S, Kallen, K, Kiessling, R, Schuessler-Lenz, M, Singh, H, Talmadge, J, Zwierzina, H, Håkansson, L
Published in European Journal of Cancer (01.05.2009)
Published in European Journal of Cancer (01.05.2009)
Get full text
Journal Article
Thalidomide and its analogues have distinct and opposing effects on TNF‐α and TNFR2 during co‐stimulation of both CD4+ and CD8+ T cells
MARRIOTT, J. B., CLARKE, I. A., DREDGE, K., MULLER, G., STIRLING, D., DALGLEISH, A. G.
Published in Clinical and experimental immunology (01.10.2002)
Published in Clinical and experimental immunology (01.10.2002)
Get full text
Journal Article
Treatment patterns, outcomes, and resource utilization of patients with metastatic melanoma in the U.K.: the MELODY study
Lorigan, P., Marples, M., Harries, M., Wagstaff, J., Dalgleish, A.G., Osborne, R., Maraveyas, A., Nicholson, S., Davidson, N., Wang, Q., Pericleous, L., Bapat, U., Middleton, M.R.
Published in British journal of dermatology (1951) (01.01.2014)
Published in British journal of dermatology (1951) (01.01.2014)
Get full text
Journal Article